Results 211 to 220 of about 28,422 (269)

Omalizumab Therapy for Bullous Pemphigoid: A Case Report. [PDF]

open access: yesCureus
Alsantali A   +5 more
europepmc   +1 more source

Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. [PDF]

open access: yesRespir Res
Bourdin A   +12 more
europepmc   +1 more source

A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods. [PDF]

open access: yesFront Allergy
Long AJ   +27 more
europepmc   +1 more source

Omalizumab

Drugs, 2001
* Omalizumab is a recombinant humanised monoclonal antibody which specifically binds to the C epsilon3 domain of immunoglobulin (Ig) E, the site of high-affinity IgE receptor binding. * Improvements in asthma symptoms and health-related quality-of-life, and a significant reduction in the frequency of asthma exacerbations were seen in allergic asthmatic
S, Easthope, B, Jarvis
openaire   +3 more sources

Home - About - Disclaimer - Privacy